NanoVibronix Inc. (NAOV): Enterprise Value to EBITDA Ratio
The current EV/EBITDA chart for NanoVibronix, Inc. (NAOV), which stands at 0.00, illustrates the position of the developer of ultrasonic systems for skin wound healing and pain relief. The firm's success relies on the sale of specialized patches, while management focuses on securing insurance reimbursements. The innovative wave therapy ecosystem enables the minimization of antibiotic use in catheter care.
Comprehensive metric breakdowns and analytics for NanoVibronix Inc. (NAOV)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
NAOV - Net Financial Result|Projected Future Earnings NanoVibronix, Inc.|NAOV - Price to Earnings Ratio|Forward P/E Multiple NanoVibronix|NAOV - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NanoVibronix, Inc.|NAOV - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months NanoVibronix|NAOV - Earnings per share for the trailing year|Quarterly EPS earnings growth nanovibronix.com|NAOV - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year NanoVibronix, Inc.
- sales volume and revenue indicators:
Analysis of all company metrics:NanoVibronix NAOV
The development of therapeutic devices and the implementation of ultrasound catheters require significant capital expenditures, making the capital structure of NanoVibronix, Inc. (NAOV) sensitive to debt. The multiple compares the total enterprise value with operating profit before depreciation and amortization (EBITDA), neutralizing the impact of debt load on the valuation. By analyzing the EV/EBITDA valuation trend, an investor can identify an entry point at historical lows or detect signs of a systemic crisis.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (pulmonx.com) - Enterprise Value to EBITDA Ratio|TELA Bio - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA sensushealthcare.com SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex (ZYXI)|electrocore.com (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IRIDEX Corporation IRIX|ibs.inc (INBS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XAIR (Beyond Air)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Profusa, Inc.|Enterprise Value to EBITDA Ratio STRATA Skin (SSKN)|EV/EBITDA Multiple GCTK|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BioSig Technologies, Inc. (BSGM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation CUTR|KNW (Know Labs) - EV/EBITDA Multiple|EV/EBITDA Multiple Inari Medical Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|reshapelifesciences.com - Enterprise Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Silk Road Medical, Inc SILK
